Argentine tie-up set to become first NYSE-listed LatAm biotech group

Linklaters in New York and Marval, O'Farrell & Mairal in Buenos Aires have helped Argentine biotech group Bioceres enter a share exchange agreement worth US$456 million with private equity-owned Union Acquisition Corporation (UAC), paving the way for its listing on the New York Stock Exchange.

Get unlimited access to all Latin Lawyer content